Due to a high incidence of rHuEPO-associated PRCA cases and high frequency of HLA-DRB1*09 in Thailand, here, we successfully used in silico tool to design EPO mutants to disrupt the EPO-T cell interaction. The gene discussed is EPO; the disease is pure red-cell aplasia.